Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Cardiovascular Innovation
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Participate in Research
  3. Brain

Brain

Recruiting

Validating markers for Alzheimer's disease

The purpose of this study is to collect brain scans, blood samples, memory test scores and cerebrospinal fluid from people with Alzheimer's disease (AD), mild cognitive impairment or no memory impairment. The information collected in the study may help characterize the early stages of AD, and shape the criteria for earlier diagnosis and treatment of AD. It will also be used to discover, standardize and validate measures and biomarkers that are used in AD research. The ADNI4 study is a continuation of the ADNI3 study and will also open to enroll new participants.

Status
Recruiting
Principal Investigator
Ging-Yuek Robin Hsiung
Body Locations and Systems
Brain and Nerves
Alzheimer's Disease
Dementia
Age
55-90

Investigating the safety of frexalimab in adults with relapsing MS

The purpose of this study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral dose of teriflunomide in male and female participants with relapsing forms of multiple sclerosis who are 18 to 55 years of age at the time of enrollment. 

Status
Recruiting
Principal Investigator
Alice Schabas
Body Locations and Systems
Brain and Nerves
Multiple Sclerosis
Immune System
Age
18-55

Collecting data for the Pacific Parkinson’s Research Centre Biobank

The purpose of this study is to collect biospecimens (fecal, urine, blood) and clinical data to serve as a resource for future research on Parkinson’s disease and other movement disorders. The careful collection, storage and retrieval of biospecimens and medical information for research projects are critical for improving understanding of healthy development and disease mechanisms and the subsequent development of effective treatments. Biospecimens from this biobank will be made available for ethically-approved studies.

Status
Recruiting
Principal Investigator
Silke Appel-Cresswell
Body Locations and Systems
Blood, Heart and Circulation
Brain and Nerves
Parkinson's Disease
Digestive System
Immune System
Kidneys and Urinary System
Mouth and Teeth
Age
19 and above

Utilizing machine learning to optimize Parkinson's disease treatment

The purpose of this study is to develop a means, via a wearable sensor, to detect the subtle physiological changes that may occur before wearing off (WO) of a Parkinson's disease treatment called levodopa become consciously felt to allow for medication to be taken and absorbed in time to prevent the WO from occurring.

Status
Recruiting
Principal Investigator
Martin McKeown
Body Locations and Systems
Brain and Nerves
Parkinson's Disease
Age
18-85

GEMINI 1

The purpose of this study is to assess the efficacy of two drug treatments measured by annualized adjudicated relapse rate (ARR) in participants with relapsing forms of MS.

Status
Recruiting
Principal Investigator
Virginia Devonshire
Body Locations and Systems
Brain
Multiple Sclerosis
Age
18 - 55

Asian Cohort for Alzheimer’s Disease

The purpose of this study is to investigate the impact of genetic and non-genetic risk factors for Alzheimer’s disease (AD), evaluate differential
effects of sex on AD risk, and predict diagnosis of AD using dementia risk scores derived from genetic and nongenetic risk factors.

Status
Recruiting
Principal Investigator
Ging-Yuek Robin Hsiung
Body Locations and Systems
Brain
Alzheimer's Disease
Age
60 and above

PORT Trial

The purpose of this study is to evaluate the feasibility of using repetitive transcranial magnetic stimulation (rTMS) to treat depression. 

Status
Recruiting
Principal Investigator
Fidel Vila-Rodriguez
Body Locations and Systems
Brain
Area
Vancouver
Age
18 and above

Understanding perimenopausal brain health

The purpose of this study is to is to examine the effects of 12 weeks of high-intensity interval training on the cognitive health of perimenopausal women.

Status
Recruiting
Principal Investigator
Teresa Liu-Ambrose
Body Locations and Systems
Brain and Nerves
Brain
Women's Health
Menopause
Area
Vancouver
Age
40-55

A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (O'HAND)

The purpose of this study is to evaluate the efficacy and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple sclerosis (PPMS).

Status
Recruiting
Principal Investigator
Alice Schabas
Body Locations and Systems
Multiple Sclerosis
Area
Vancouver
Age
18 - 65

Co-Investigation of Robotic-Assisted Virtual Care for Older People with Dementia - Phase 1

The purpose of this study is to determine ways to meet the social needs related to loneliness and isolation in seniors with dementia while examing barriers and successes surrounding the use of a robot-assisted, virtual care solution within care settings. 

Status
Recruiting
Principal Investigator
Lillian Hung
Body Locations and Systems
Dementia
Area
Vancouver
Age
18 and above

Treating Anxiety in Parkinson's Disease With a Multi-Strain Probiotic (TAP)

The purpose of this study is to evaluate the use of an oral multi-strain probiotic in the treatment of anxiety in individuals with Parkinson's Disease. 

Status
Recruiting
Principal Investigator
Silke Appel-Cresswell
Body Locations and Systems
Parkinson's Disease
Area
Vancouver
Age
40 - 80

PRidopidine's Outcome On Function in Huntington Disease (PROOF- HD)

The purpose of this study is to evaluate the efficacy and safety of the drug pridopidine in patients with early stage manifest Huntington Disease.

Status
Recruiting
Principal Investigator
Blair Leavitt
Body Locations and Systems
Huntington's Disease
Area
Vancouver
Age
18 and above

Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease

The purpose of the study is to better understand the safety of using combination antithrombotic therapy in patients with high risk transient ischemic attack (TIA) or ischemic stroke secondary to ICAD (intracranial atherosclerotic disease) for prevention of recurrent stroke.

Status
Recruiting
Principal Investigator
Samuel Yip
Body Locations and Systems
Stroke
Area
Vancouver
Age
40 and above

A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205

The purpose of the study is to evaluate the long-term safety and tolerability of aducanumab  in participants who had previously participated in aducanumab studies.

Status
Recruiting
Principal Investigator
Ging-Yuek Robin Hsiung
Body Locations and Systems
Alzheimer's Disease
Area
Vancouver
Age
18 and above

The Effect of Exercise on Brain Energetics in Parkinson’s disease

This project will explore the effect of exercise on brain energetics using functional MRI and PET imaging in people with Parkinson's disease.

Status
Recruiting
Principal Investigator
Vesna Sossi
Body Locations and Systems
Parkinson's Disease
Area
Vancouver
Age
40-80

Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL)

The purpose of the study is to examine the feasibility and effectiveness of a 4-week lower extremity telerehabilitation protocol with aims to improve lower extremity recovery amoung community-living stroke survivors. 

Status
Recruiting
Principal Investigator
Brodie Sakakibara
Body Locations and Systems
Stroke
Area
Vancouver
Age
19 and above

The NEUROlogically-impaired Extubation Timing Trial (NEURO-ETT)

This randomized controlled trial will enrol patients with acute severe brain injury who pass a spontaneous breathing trial but have decreased level of consciousness. It will directly compare (1) prompt extubation vs. (2) prompt tracheostomy vs. (3) usual care, with extubation or tracheostomy timed according to physicians' discretion. The primary outcome will be ICU free days (days spent alive and outside an ICU).

Status
Recruiting
Principal Investigator
Donald Griesdale
Body Locations and Systems
Brain
Lungs and Breathing
Area
Vancouver
Age
16 and above

Multiple Sclerosis, Genes, Microbes, and Medication

The purpose of the main study is to investigate adverse drug reactions from multiple sclerosis (MS) disease modifying drugs by understanding the genetic factors that contribute to their cause. 

The sub-study investigates how the MS disease modifying drugs affect microbes in the gut and how human DNA affects the changes in the gut microbes following drug treatment. We are also interested in how gut microbes might relate to progressive MS.

recruitment poster

Status
Recruiting
Principal Investigator
Helen Tremlett
Body Locations and Systems
Multiple Sclerosis
Immune System
Area
Vancouver
Age
18 and above

Correlation Between PET and Advanced MRI in Multiple Sclerosis

This is an observational study designed to determine the relationship between quantitative advanced MRI measures and OCT with PET measurements of microglial activation and myelin health. 

Status
Recruiting
Principal Investigator
Robert Carruthers
Body Locations and Systems
Multiple Sclerosis
Area
Vancouver
Age
18-60

Brain Health and Exercise in Schizophrenia (PEHP)

To determine the effects of aerobic exercise on hippocampal volumes and severity of psychotic symptoms in a population of psychosis patients compared to healthy age/gender matched volunteers. Psychosis patients often suffer from a number of cognitive difficulties, including poor memory function, poor problem-solving capacity and difficulties with attention and concentration. These problems are not well addressed by current clinical treatments.

Status
Recruiting
Principal Investigator
Donna Jane M Lang
Body Locations and Systems
Brain
Area
Vancouver
Age
16-45

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page
Subscribe to Brain

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy